193 related articles for article (PubMed ID: 19076443)
1. Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson's disease.
Henchcliffe C; Shungu DC; Mao X; Huang C; Nirenberg MJ; Jenkins BG; Beal MF
Ann N Y Acad Sci; 2008 Dec; 1147():206-20. PubMed ID: 19076443
[TBL] [Abstract][Full Text] [Related]
2. Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal.
Schapira AH
Mov Disord; 1994 Mar; 9(2):125-38. PubMed ID: 8196673
[TBL] [Abstract][Full Text] [Related]
3. Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease.
Hattingen E; Magerkurth J; Pilatus U; Mozer A; Seifried C; Steinmetz H; Zanella F; Hilker R
Brain; 2009 Dec; 132(Pt 12):3285-97. PubMed ID: 19952056
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research.
Stork C; Renshaw PF
Mol Psychiatry; 2005 Oct; 10(10):900-19. PubMed ID: 16027739
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson's disease.
Weiduschat N; Mao X; Beal MF; Nirenberg MJ; Shungu DC; Henchcliffe C
J Neuroimaging; 2015; 25(1):105-10. PubMed ID: 24325203
[TBL] [Abstract][Full Text] [Related]
6. A mitochondrial etiology of neurodegenerative diseases: evidence from Parkinson's disease.
Khusnutdinova E; Gilyazova I; Ruiz-Pesini E; Derbeneva O; Khusainova R; Khidiyatova I; Magzhanov R; Wallace DC
Ann N Y Acad Sci; 2008 Dec; 1147():1-20. PubMed ID: 19076426
[TBL] [Abstract][Full Text] [Related]
7. Parkinson disease: primacy of age as a risk factor for mitochondrial dysfunction.
Vanitallie TB
Metabolism; 2008 Oct; 57 Suppl 2():S50-5. PubMed ID: 18803967
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance spectroscopy in Parkinson's disease and parkinsonian syndromes.
Rango M; Arighi A; Biondetti P; Barberis B; Bonifati C; Blandini F; Pacchetti C; Martignoni E; Bresolin N; Nappi G
Funct Neurol; 2007; 22(2):75-9. PubMed ID: 17637209
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging and spectroscopy in Parkinson's disease.
Martin WR
Adv Neurol; 2001; 86():197-203. PubMed ID: 11553978
[TBL] [Abstract][Full Text] [Related]
10. Evidence for mitochondrial dysfunction in patients with alternating hemiplegia of childhood.
Arnold DL; Silver K; Andermann F
Ann Neurol; 1993 Jun; 33(6):604-7. PubMed ID: 8498840
[TBL] [Abstract][Full Text] [Related]
11. In vivo evidence for cerebral depletion in high-energy phosphates in progressive supranuclear palsy.
Stamelou M; Pilatus U; Reuss A; Magerkurth J; Eggert KM; Knake S; Ruberg M; Schade-Brittinger C; Oertel WH; Höglinger GU
J Cereb Blood Flow Metab; 2009 Apr; 29(4):861-70. PubMed ID: 19190655
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial abnormalities and oxidative imbalance in neurodegenerative disease.
Ogawa O; Zhu X; Perry G; Smith MA
Sci Aging Knowledge Environ; 2002 Oct; 2002(41):pe16. PubMed ID: 14603007
[TBL] [Abstract][Full Text] [Related]
13. Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: relevance to Parkinson's disease.
Arduíno DM; Esteves AR; Cardoso SM; Oliveira CR
Neurochem Int; 2009 Sep; 55(5):341-8. PubMed ID: 19375464
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance spectroscopy in migraine: what have we learned so far?
Reyngoudt H; Achten E; Paemeleire K
Cephalalgia; 2012 Aug; 32(11):845-59. PubMed ID: 22763498
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction and Parkinson's disease genes: insights from Drosophila.
Park J; Kim Y; Chung J
Dis Model Mech; 2009; 2(7-8):336-40. PubMed ID: 19553694
[TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease and brain mitochondrial dysfunction: a functional phosphorus magnetic resonance spectroscopy study.
Rango M; Bonifati C; Bresolin N
J Cereb Blood Flow Metab; 2006 Feb; 26(2):283-90. PubMed ID: 16094320
[TBL] [Abstract][Full Text] [Related]
17. Assessment of in vitro and in vivo mitochondrial function in Friedreich's ataxia and Huntington's disease.
Schapira A; Lodi R
Methods Mol Biol; 2004; 277():293-307. PubMed ID: 15201464
[TBL] [Abstract][Full Text] [Related]
18. Intact presupplementary motor area function in early, untreated Parkinson's disease.
Martin WR; Wieler M; Gee M; Hanstock CC; Camicioli RM
Mov Disord; 2008 Sep; 23(12):1756-9. PubMed ID: 18709678
[TBL] [Abstract][Full Text] [Related]
19. [Mitochondrial dysfunction in bipolar disorder].
Kato T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Apr; 25(2):61-72. PubMed ID: 16220655
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications.
Khan SA; Cox IJ; Hamilton G; Thomas HC; Taylor-Robinson SD
Liver Int; 2005 Apr; 25(2):273-81. PubMed ID: 15780050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
